HOME >> MEDICINE >> NEWS
NHS could save 2bn by using generic cholesterol drugs

The NHS in England could save over 2bn in the next five years if doctors simply switched patients to cheaper generic cholesterol lowering drugs (statins), say two senior doctors in this week's BMJ.

Statins are one of the great success stories of preventive medicine, write James Moon and Richard Bogle. Prescriptions have increased by 30% every year in England and statins represent the largest part of the NHS drug bill (738 million in 2004).

Statin prescribing is dominated by atorvastatin and simvastatin and over 40% of all prescribing is for atorvastatin. The majority (85%) of these prescriptions are for the lower doses of atorvastatin (10 and 20 mg). In May 2003 the UK simvastatin patent expired and in 2006 simvastatin costs six times less than atorvastatin.

This fall in price will save the NHS about 1bn in the next five years, say the authors. However, atorvastatin will remain on patent until 2011 and by simply switching from the expensive lower doses of atorvastatin to cheaper simvastatin, doctors could save a further 1 billion.

The number of statin prescriptions is set to rise sharply following the publication of new guidelines from the National Institute for Health and Clinical Excellence (NICE). These guidelines recommend that 5.2 million (14% of the adult population) should be taking statins and this will cost an extra 250m per year. If generic simvastatin was universally prescribed for these people, the costs would actually fall by 185m a year.

Several large independent studies have proven that both statins are equally safe and effective. The only important difference is cost. So, is there any justification to continue to prescribe lower doses of atorvastatin when simvastatin 40mg is so much cheaper, ask the authors?

At University College London Hospitals NHS Foundation Trust simvastatin is now the first line statin. This simple change will save the trust 80,000 a year. Switching programmes to replace lower dos
'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
8-Jun-2006


Page: 1 2

Related medicine news :

1. Seat belt injuries could signal more serious trauma in children
2. Using MRI for diagnosis could help prevent breast cancer progression
3. Metabolic study in mice could lead to good cholesterol boosters
4. Miniature implanted devices could treat epilepsy, glaucoma
5. Health reform bills could improve quality and efficiency, but fall short of national plan
6. Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention
7. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
8. Oxygen trick could see organic costs tumble
9. New study could bring relief to sweltering city slickers
10. Decision aid tool could cut the number of Caesarean sections by 4000 a year
11. Papillomavirus vaccine could substantially reduce cervical cancer incidence

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
Breaking Medicine Technology:
Cached News: